• Rosacea

Oracea Generic Name & Formulations

General Description

Doxycycline 40mg (30mg immediate-release beads, 10mg delayed-release beads); caps.

Pharmacological Class

Tetracycline antibiotic.

How Supplied


Oracea Indications


Treatment of only inflammatory lesions (papules and pustules) of rosacea.

Limitations of Use

This formulation has not been evaluated in the treatment or prevention of infections. Not been evaluated for the treatment of erythematous, telangiectatic, or ocular components of rosacea.

Oracea Dosage and Administration


Take on empty stomach in the morning with sufficient amount of fluids. 40mg once daily.


Not recommended.

Oracea Contraindications

Not Applicable

Oracea Boxed Warnings

Not Applicable

Oracea Warnings/Precautions


Do not substitute with other doxycycline products. Renal impairment. Hepatic insufficiency. Monitor blood, renal and hepatic function. Achlorhydria. GI surgery. Predisposition to candidiasis overgrowth. Avoid sun and UV light. Discontinue if superinfection occurs; treat appropriately. Monitor for autoimmune syndromes, visual disturbances. Labor & delivery. Pregnancy (during 2nd & 3rd trimester): avoid. Nursing mothers: not recommended (during and for 5 days after the last dose).

Oracea Pharmacokinetics

See Literature

Oracea Interactions


Avoid concomitant methoxyflurane, penicillins, photosensitizers, oral retinoids. Reduced absorption with bismuth subsalicylate, acid pump inhibitors, antacids, calcium, magnesium, iron. May potentiate anticoagulants (eg, warfarin). May antagonize hormonal contraceptives (use back-up contraception). May be antagonized by metabolic enzyme inducers (eg, barbiturates, carbamazepine, phenytoin).

Oracea Adverse Reactions

Adverse Reactions

Nasopharyngitis, sinusitis, superinfection, diarrhea, dry mouth, hypertension, blood glucose increase, elevated liver enzymes or BUN; C.difficile-associated diarrhea, autoimmune syndromes (discontinue if occurs), hyperpigmentation, photosensitivity, teeth discoloration, pseudotumor cerebri, others (see full labeling).

Oracea Clinical Trials

See Literature

Oracea Note

Not Applicable

Oracea Patient Counseling

See Literature